13
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Primary biliary cirrhosis in female subjects with sicca-associated antibodies

, , , , , , & show all
Pages 486-491 | Received 02 Jul 2007, Accepted 20 Aug 2007, Published online: 02 Jan 2014

References

  • Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261–73.
  • Bell M, Askari A, Bookman A, Frydrych S, Lamont J, McComb J, et al. Sjogren's syndrome: a critical review of clinical management. J Ftheumatol 1999;26:2051–61.
  • Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003;98:431–7.
  • Chou MJ, Lee SL, Chen TY, Tsay GJ. Specificity of antinuclear antibodies in primary biliary cirrhosis. Ann Rheum Dis 1995;54: 148–51.
  • McCarty GA, Rice JR, Bembe ML, Barada FA Jr. Anticentromere antibody: Clinical correlations and association with favorable prognosis in subjects with scleroderma variants. Arthritis Rheum 1983;26:1–7.
  • Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, et al. Systemic sclerosis-associated Sjogren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 2006;54: 2243–9.
  • Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibod-ies. J Ftheumatol 2005;32:1488–94.
  • Takada K, Suzuki K, Okada M, Nakashima M, Ohsuzu F. Salivary production rates fall with age in subjects having anticentromere, anti-Ro, and/or anti-La antibodies. Scand J Ftheumatol 2006;35: 23–8.
  • Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, et al. Anti-gp210 and anticentromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007;45:118–27.
  • Powell FC, Schroeter AL, Dickson ER. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med 1987; 62:75–82.
  • Nakano T, Inoue K, Hirohara J, Arita S, Higuchi K, Omata M, et al. Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptom-atic PBC (a-PBC). Hepatol Res 2002;22:250–60.
  • Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929–38.
  • Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European Study Group on classification criteria for Sjögren's syndrome. Classification criteria for Sjögren's 21. syndrome: a revised version of the European criteria proposed by the American—European Consensus Group. Ann Rheum Dis 2002; 61:554–8.
  • LeRoy EC, Trojanowska M, Smith EA. The pathogenesis of sclero- 22. derma (systemic sclerosis, SSc). Clin Exp Ftheumatol 1991;9: 173–7.
  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper 23. NS, et al. The American Rheumatism Association 1987 revised cri-teria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31: 315–24.
  • Poupon R, Poupon RE. Primary biliary cirrhosis. In: Zakim D, 24. Boyer TD, editors. Hepatology a textbook of liver disease. 3rd ed. Philadelphia: WB Saunders; 1996. p. 1329–65.
  • Poupon R, Chazouilleres 0, Poupon RE. Chronic cholestatic disease. J Hepatol 2000;32:129-40.25.
  • Ohba K, Omagari K, Kinoshita H, Soda H, Masuda J, Hazama H, et al. Primary biliary cirrhosis among atomic bomb survivors in Nagasaki, Japan. J Clin Epidemiol 2001;54:845–50.
  • Pratt DS, Kaplan MM. Evaluation of the liver: laboratory test. In: 26. Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff s disease of the liver. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 221–55.
  • Van Hoof VO, Hoylaerts MF, Geryl H, Van Mullem M, Lepoutre LG, De Broe ME. Age and sex distribution of alkaline phosphatase isoenzymes by agarose electrophoresis. Clin Chem 1990;36:875–8.
  • Iki M, Morita A, Ikeda Y, Sato Y, Akiba T, Matsumoto T, et al. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women: the Japanese population-based osteoporosis (JPOS) Cohort Study. Osteoporos Int 2006;17:1086–95.
  • Minisola S, Pacitti MT, Ombricolo E, Costa G, Scarda A, Palombo E, et al. Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without frac-tures. Maturitas 1998;29:265–70.
  • Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, et al. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Clin Biochem 2003;36:203–10.
  • Nakanuma Y, Harada K, Kaji K, Terasaki S, Tsuneyama K, Moteki S, et al. Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies. Liver 1997;17: 281–7.
  • Fox PC. Autoimmune diseases and Sjogren's syndrome: an autoim-mune exocrinopathy. Ann NY Acad Sci 2007;1098:15–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.